恩典生命科技(02112.HK)中期扭亏为盈至约20万美元

Group 1 - The company reported revenue of approximately $8.42 million for the six months ending June 30, 2025, compared to $5.97 million for the same period ending June 30, 2024 [1] - The company achieved a profit of approximately $200,000 during the period, a significant improvement from a loss of approximately $9 million in the previous period [1] - The board of directors does not recommend the payment of an interim dividend for the period, consistent with the previous period where no dividend was paid [1]